Ghirardi L, Kuja-Halkola R, Butwicka A, Martin J, Larsson H, Donofrio BM, et al
Garcia, A
Nature 365: 185188 Winter J, Klappa P, Freedman RB, Lilie H, Rudolph R (2002) Catalytic activity and chaperone function of human proteindisulfide isomerase are required for the efficient refolding of proinsulin
10.1128/mBio.01399-18 15 CamachoE.Gonzlez-De la FuenteS.SolanaJ
These findings indicate that chemically modified DNA aptamers can surpass previous RNA aptamers, presenting a viable approach for targeted cancer therapy and potential for further clinical use [93]
Heres how its different from previous meds: Retatrutide is a triple agonist, meaning it targets three different hormone receptors, rather than one (like Ozempic) or two (like Mounjaro or Zepbound)